文献速递外周动脉疾病

静脉动脉化治疗动脉粥样硬化性慢性肢体威胁性缺血患者的Meta分析

Deep Venous Arterialization for Chronic Limb Threatening Ischemia in Atherosclerosis Patients - A Meta-Analysis.
PubMed 文献 · Ann Vasc Surg · 2021-12-07

本Meta分析纳入12项研究、442例患者共445条肢体,评估静脉动脉化治疗动脉粥样硬化性慢性肢体威胁性缺血(CLTI)的结局。汇总30天死亡率为3.7%、1年保肢率为79.0%、1年生存率为85.7%,但研究证据水平低,需更多随机对照试验或高质量队列研究进一步明确该手术的有效性。

要点

  • 静脉动脉化治疗CLTI的汇总1年保肢率为79.0%(95%CI 68.7-90.7)。
  • 汇总30天死亡率为3.7%(95%CI 0.8-6.6%),30天主要不良肢体事件为16.7%(95%CI 1.5-31.9%)。
  • 结论基于低水平证据,需更多随机对照试验或高质量队列研究进一步明确有效性。

核心结论

  • 静脉动脉化治疗CLTI的1年保肢率79%可接受,但基于低水平证据,需更多随机对照试验或高质量队列研究进一步明确该手术的有效性。

研究设计与样本

  • 系统综述与Meta分析,遵循PRISMA方法检索5个数据库,纳入英文原创研究论文,对象为接受静脉动脉化治疗的CLTI患者。
  • 排除标准:非动脉粥样硬化所致CLTI、重复研究或患者报告、仅会议摘要。
  • 共纳入12项研究、442例患者、445条肢体,其中374例患者377条肢体接受静脉动脉化,其余接受传统旁路手术作为对照。
  • 对样本量≥10的文章采用随机效应模型进行Meta分析,并评估研究质量与偏倚风险。

主要发现

  • 平均年龄66岁(18项研究,范围37-91岁),男性占68%(271/366,15项研究),糖尿病占67%(271/406,16项研究)。
  • 大多数肢体存在组织缺损(88%,352/398,16项研究)。
  • 汇总30天死亡率为3.7%(95%CI 0.8-6.6%),30天并发症率为15.5%(95%CI 3.2-27.8%)。
  • 汇总30天主要不良心血管事件为5.2%(95%CI 1.7-8.6%),30天主要不良肢体事件为16.7%(95%CI 1.5-31.9%)。
  • 汇总1年保肢率为79.0%(95%CI 68.7-90.7%),1年生存率为85.7%(95%CI 76.2-96.4%)。

局限性

  • 结论基于低水平证据。
  • 研究质量在各研究间差异显著。
  • 需更多随机对照试验或高质量队列研究进一步明确该手术的有效性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Venous arterialization is an upcoming and novel alternative in chronic limb threatening ischemia (CLTI) patients in the absence of standard revascularization options. The aim of this study is to systematically review and analyze outcomes of venous arterialization. METHODS: A systematic literature search was performed in 5 databases using the PRISMA methodology. Inclusion criteria were English language original research papers on CLTI patients treated with venous arterialization. EXCLUSION CRITERIA: absence of CLTI due to atherosclerosis, duplicate study or reporting of patients, meeting abstract only. Quality and risk of bias were evaluated. Meta-analysis was performed using random effects model on articles that have a sample size of equal or greater than 10. RESULTS: Twelve studies included 442 patients that underwent treatment for 445 limbs (374 patients and 377 limbs underwent venous arterialization while remainder underwent traditional bypass and served as control subjects). Average age was 66 [18 studies, range 37 -91 years], 68% were male [271/366, 15 studies] and 67% diabetic [271/406, 16 studies]). Most limbs (88%, 352/398, 16 studies) had tissue loss. Pooled 30-day mortality was 3.7% (95%-confidence interval [CI] 0.8 -6.6%), 30-day morbidity was 15.5% (95%-CI 3.2 -27.8%), 30-day major adverse cardiovascular event was 5.2% (95%-CI 1.7 -8.6%) and 30-day major adverse limb event was 16.7% (95%-CI 1.5 -31.9%). Pooled 1-year limb-salvage rate was 79.0% (95%-CI 68.7 -90.7) and 1-year survival rate was 85.7% (95%-CI 76.2 -96.4). Studies quality varied significantly across studies. CONCLUSION: Venous arterialization has an acceptable a 1-year limb salvage rate of 79%, however, this is based on low levels of evidence. More randomized controlled trials or high-quality cohort studies are needed to further define the effectiveness of this procedure for CLTI.

来源:Ann Vasc Surg,查看原文。版权归原作者所有。

引用

  1. Yan Q, Prasla S, Carlisle DC, et al. Deep Venous Arterialization for Chronic Limb Threatening Ischemia in Atherosclerosis Patients - A Meta-Analysis. Ann Vasc Surg. 2021. PMID: 34883231. doi:10.1016/j.avsg.2021.10.059

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。